Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > AGM - Complete Waste of Time
View:
Post by QContinuum1 on Jun 26, 2024 11:15am

AGM - Complete Waste of Time

Truly.  As expected but very very disappointing.

Nothing of colour added except for:

1) The expected 'very excited' to add the pocket change that Remidose has added to the portfolio
2) Drobinonol is a big deal in Germany
3) Australia is doing ok via Beacon and the GMP restrictions

So basically nothing new and certainly nothing of note.  Not even commentary on the depressed SP.

I am very disappointed and upset at the moment.  While not expecting the world, was certainly expecting a bit more dialogue given just how pathetic the SP has been and what exactly management is doing about it.

Comment by Starkicker on Jun 26, 2024 2:42pm
I am so glad I gassed my investment in this company.  It's like having a girlfriend that won't put out, but she keeps teasing.
Comment by mdjbrown on Jun 27, 2024 6:11pm
No question frustrations are building Starkicker Been holding here more than 3 years and in the red.  Took a .24 cent chance on AVCN earlier this month and almost double ROI in less than 30 days, and both of these companies are in the same space. Something has to give with Medipharm for its shareholders!
Comment by Lvlchange on Jun 27, 2024 6:37pm
I don't understand.  MFL's doesn't make money, what do you think?  Why would you make money on investing in a company that doesn't make $.   The revenue is also garbage.  Absolute garbage, let's get to 500 million of revenue a year then maybe someone will come sniffing around.   I like this company, but they are far from being anywhere near the big ...more  
Comment by Solid1 on Jun 28, 2024 3:11am
GW Pharmaceuticals also did not make any money until Epidiolex was approved 
Comment by Starkicker on Jun 27, 2024 8:17pm
Glad you're making money somewhere MDJ! I remember the early days when MPL issued press releases for just about everything. Weren't they in Paraguay or Uruguay or something with big expectations? Theyjust can't seem to generate any revenue and it doesn't seem like that will ever change.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities